Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2012
07/11/2012CN101869700B Chinese medicinal oral liquid for treating tumour and preparation method thereof
07/11/2012CN101837122B Genetic engineering composite peptide vaccine for inhibiting tumor angiogenesis and use thereof
07/11/2012CN101798348B Anti-uPAR humanized antibody and application thereof
07/11/2012CN101791295B Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing frozen powder injection
07/11/2012CN101773471B Mitoxantrone targeting sustained-release long-circulating nanometer liposome and preparation method
07/11/2012CN101698003B Method for separating rhizoma corydalis total alkaloids by ion exchange resin
07/11/2012CN101573448B Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
07/11/2012CN101570571B Truncated human papilloma virus 18 type L1 protein
07/11/2012CN101429174B Piperazine derivant with antineoplastic activity
07/11/2012CN101384600B Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
07/11/2012CN101288641B Coenzyme Q10 water dispersion and preparation method thereof
07/11/2012CN101243187B Method of producing lymphocytes
07/11/2012CN101161283B New use of CMTM1-v17 and its antagon
07/11/2012CN101147803B Anti Toll-like receptor 2 antibody inhibiting tumor metastasis use
07/11/2012CN101081870B Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof
07/11/2012CN101054417B Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
07/11/2012CN101006065B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
07/10/2012US8217177 Fused heterocyclic derivatives and methods of use
07/10/2012US8217138 Anti-inflammatory compounds and uses thereof
07/10/2012US8217077 HMB uses thereof
07/10/2012US8217051 Spiroindolinone derivatives
07/10/2012US8217017 Modulation of insulin like growth factor I receptor expression
07/10/2012US8217016 Application of mRNA for use as a therapeutic agent for tumorous diseases
07/10/2012US8217010 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
07/10/2012US8216792 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
07/10/2012US8216587 Method of vaccination
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/10/2012US8216569 Vascular endothelial growth factor 2
07/10/2012US8216564 Herpes simplex virus (HSV) derived amplicon defective viral genome carrying at least one toxic foreign gene and an HSV-derived mutant helper virus; antitumor and anticarcinogenic agents
07/10/2012CA2706832C Mevalonic acid derivatives
07/10/2012CA2601955C Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
07/10/2012CA2588415C 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
07/10/2012CA2562535C 2-alkylidene-18,19-dinor-vitamin d compounds
07/10/2012CA2542909C 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
07/10/2012CA2533749C Piperidine compounds useful as malonyl-coa decarboxylase inhibitors
07/10/2012CA2526430C Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
07/10/2012CA2519898C Oral administration of cyclic protein tyrosine kinase inhibitors
07/10/2012CA2503549C Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
07/10/2012CA2500387C A controlled release system containing temozolomide
07/10/2012CA2498420C Lipophilic diesters of chelating agent for inhibition of enzyme activity
07/10/2012CA2485253C Lipid a and other carbohydrate ligand analogs
07/10/2012CA2479341C Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
07/10/2012CA2477954C Means and methods for the production of adenovirus vectors
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2462564C Methods of inhibiting metastases
07/10/2012CA2446951C Polythiourea lipid derivatives
07/10/2012CA2444821C Combination therapy using anti-angiogenic agents and tnfa
07/10/2012CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
07/10/2012CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells
07/10/2012CA2429543C Method for obtaining antigenic aggregates and the use thereof in formulations
07/10/2012CA2417311C Crystalline alkali metal salts of lansoprazole and their production and use
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
07/10/2012CA2342040C Anaerobic bacterium as a drug for cancer gene therapy
07/10/2012CA2291928C Produits anti-cancereux pour le traitement de la mucoviscidose
07/10/2012CA2211324C Recombinant human alpha-fetoprotein and uses thereof
07/05/2012WO2012092616A1 Conjugated anti-cd38 antibodies
07/05/2012WO2012092612A1 Anti-cd38 antibodies
07/05/2012WO2012092569A2 Compositions comprising immunostimulatory nucleic acids and related methods
07/05/2012WO2012092539A2 Antibodies to dll4 and uses thereof
07/05/2012WO2012092471A2 Novel tubulin inhibitors and methods of using the same
07/05/2012WO2012092442A1 Therapeutic compounds and compositions
07/05/2012WO2012092288A2 Compositions and methods of using crystalline forms of wortmannin analogs
07/05/2012WO2012092114A2 Oxidosqualene cyclase as a protein target for anticancer therapeutics
07/05/2012WO2012091718A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer
07/05/2012WO2012091564A2 A cross-linking polypeptide that induces apoptosis
07/05/2012WO2012091563A1 A polypeptide that binds aberrant cells and induces apoptosis
07/05/2012WO2012091496A2 siRNA FOR INHIBITION OF Hif1α EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
07/05/2012WO2012091220A1 Composition for the prevention or treatment of neoplastic diseases, comprising mirna as an active ingredient
07/05/2012WO2012091137A1 GENE THERAPEUTIC AGENT USING TNF-α, CD40L, AND GM-CSF IN COMBINATION
07/05/2012WO2012091136A1 Expression vector, method for producing carrier using same, and use of same
07/05/2012WO2012090939A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells
07/05/2012WO2012090221A1 Novel salts of imatinib
07/05/2012WO2012090204A1 2 - (2 - phenylethenyl) - 1, 3 -benzothiazine derivatives useful for the treatment cancer
07/05/2012WO2012089814A1 Antigen binding formats for use in therapeutic treatments or diagnostic assays
07/05/2012WO2012089768A1 System for the release of a therapeutic agent, pharmaceutical compositions containing it, the preparation and medical use thereof
07/05/2012WO2012089736A1 Sirna against cbl-b and optionally il2 und il12 for use in the treatment of cancer
07/05/2012WO2012089633A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
07/05/2012WO2012089338A1 Combination of vaccination and inhibition of mhc class restricted antigen presentation
07/05/2012WO2012089336A1 A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes
07/05/2012WO2012089225A1 Combination of vaccination and inhibition of mhc class i restricted antigen presentation
07/05/2012WO2012089137A1 Arylurea compound, intermediate and use thereof
07/05/2012WO2012089106A1 Aromatic alkyne derivative as protein kinase inhibitor and medical use thereof
07/05/2012WO2012089051A1 Benzopyrone estrogen receptor regulator
07/05/2012WO2012088777A1 Effective part of ginseng, preparing method and use thereof
07/05/2012WO2012088712A1 Compound as wnt signaling inhibitor, composition, and use thereof
07/05/2012WO2012064943A3 Metalloenzyme inhibitor compounds
07/05/2012WO2012064914A3 Peptidomimetic inhibitors of psma
07/05/2012WO2012061402A3 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
07/05/2012WO2012054564A3 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
07/05/2012WO2012050921A3 Nd2 peptides and methods of treating neurological disease
07/05/2012WO2012040623A3 Nanostructured gels capable of controlled release of encapsulated agents
07/05/2012WO2012040587A3 Compositions and methods for altering matrix rigidity to regulate cancer cell growth and phenotype
07/05/2012WO2012040527A3 Deubiquitinase inhibitors and methods for use of the same
07/05/2012WO2012039908A3 Method and compound for treatment of cancer using phosphorous-32 labeled dna
07/05/2012WO2012037553A9 Use of pkc-iota inhibitors for the treatment of breast cancer
07/05/2012WO2012037411A3 Estrogen receptor modulators and uses thereof
07/05/2012WO2012033525A3 P53-mdm2 antagonists
07/05/2012WO2012030152A3 Composition for preventing and treating prostate cancer including alpinia katsumadai hayata extract
07/05/2012WO2012028622A3 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
07/05/2012WO2012024350A3 Anti-cancer adenoviruses
1 ... 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 ... 2211